The Centers for Disease Control and Prevention (CDC) has endorsed the Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices’ (ACIP) recommendations to expand eligibility of Pfizer’s COVID-19 booster doses to kids 12 to 15 years old. CDC now recommends that adolescents aged 12 to 17 years …
Read More »